be composed of representatives of the three largest shareholders by votes listed in the shareholders' register maintained by Euroclear Sweden as of
30 June 2020 and the chairman of the board of directors acting as rapporteur. The representative appointed by the largest shareholder by votes shall be
appointed chairman of the nomination committee.

• Per-Anders Tammerlöv (chairman of the nomination committee) appointed by Rikard Akhtarzand, shareholder through direct and indirect ownership
• Per Åhlgren, shareholder through indirect ownership
• Magnus Vahlquist, shareholder through direct and indirect ownership
• Staffan Torstensson, chairman of ADDvise Group AB

The nomination committee shall prepare proposals for the 2021 annual general meeting regarding appointment of chairman of the meeting, chairman of the board of directors and other directors of the board and remuneration to the directors of the board and to the auditor.

Shareholders, who wish to present proposals to the nomination committee for the 2021 annual general meeting, can submit them by post no later than 31 January 2021 to: ADDvise Group AB, att: Nomination Committee, Grev Turegatan 3, SE-114 46 Stockholm.

The Annual General Meeting 2021 in ADDvise Group AB will be held in Stockholm on 23 April 2021.

For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business - both geographically and product wise. ADDvise Group's shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.